New Arizona’s Bioscience Roadmap Details How the State Becomes a Nationally Recognized Bioscience Hub

The Flinn Foundation has commissioned a new Arizona’s Bioscience Roadmap to guide discovery, innovation, and economic growth through 2030 The strategic plan was first launched more than two decades ago and includes goals for accelerating commercialization, empowering startups, and developing and retaining workers Developed by SRI International of Menlo Park, Calif., the plan will be … [Read more…]

Australia Acute Respiratory Distress Syndrome Market Analysis 2025-2033 | Disease Burden, Rising ICU Admissions, and Advancements in Medical Technology Drive ARDS Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Australia Acute Respiratory Distress Syndrome Market Analysis 2025” report has been added to ResearchAndMarkets.com’s offering. The Australia Acute Respiratory Distress Syndrome (ARDS) Market is expected to grow from US$ 24.82 million in 2024 to US$ 44.79 million by 2033, at a compound annual growth rate (CAGR) of 6.78% between 2025 and 2033. Growing … [Read more…]

U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease

− Approval Expands Use of VONVENDI to Include Routine Prophylaxis to Reduce the Frequency of Bleeding Episodes in Adults with Type 1 and 2 Von Willebrand Disease (VWD) and On-Demand and Perioperative Management of Bleeding in Pediatric Patients with VWD1 − VONVENDI is the Only Recombinant Von Willebrand Factor Replacement Therapy with Approved Indications in … [Read more…]

Cresso Health Announces Acquisition of GPS Insurance

NEW YORK–(BUSINESS WIRE)–Cresso Health, a technology-enabled provider of sales and marketing solutions for leading health insurance carriers in the United States, today announced it has acquired Florida-based GPS Insurance (“GPS”), a distributor of health insurance and related products. Cresso Health is backed by New York-based healthcare investor Cypress Ridge Capital. Kevin Reich, Founder of GPS, … [Read more…]

Ronovo Surgical Closes Series D Financing

Company advances commercialization in China through Targeted Collaboration Agreement with Johnson & Johnson SHANGHAI–(BUSINESS WIRE)–#artificialintelligence—Ronovo Surgical, a global innovator in next-generation surgical robotics, announced today the successful closing of its Series D financing, led by Johnson & Johnson’s corporate venture capital organization, JJDC, and participation from Lilly Asia Ventures, INCE Capital and Granite Asia, with … [Read more…]

Cosentus Invests in Accreda Healthcare Management — An Anesthesia-Exclusive RCM Provider

IRVINE, Calif.–(BUSINESS WIRE)–$RCM #Accreda—Cosentus Holdings, a premier provider in revenue cycle management (RCM) and integrated business solutions for healthcare practices, has announced a strategic investment in Accreda Healthcare Management — a purpose-built company specializing exclusively in anesthesia-focused revenue cycle management. This partnership marks a significant milestone in Cosentus’ commitment to deepening its specialization and elevating … [Read more…]

LatchBio Releases a 25 Million Cell Human Spatial Transcriptomics Atlas and Agentic Spatial Curation Tools

LatchBio provides white-labeled data infrastructure, analysis tools and delivery portals for kit, instrument, and solution providers. Today, LatchBio released a 25 million cell spatial atlas spanning 11 spatial transcriptomics technologies, including 10X Genomics Visium, Visium HD, Xenium, Bruker Spatial CosMx, STOmics Stereo-seq, Vizgen MERSCOPE, Takara Bio Seeker, AtlasXOmics DBiT-seq, Spatial Genomics GenePS (seqFISH), Element Biosciences … [Read more…]

Newron to present data and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 2025 World Congress of Biological Psychiatry (WCBP)

The importance of glutamate release modulation by evenamide used as an add-on therapy for patients with schizophrenia inadequately responding to their second-generation antipsychotics, including clozapine (study 008A) – oral and poster presentation The key features of a landmark, potentially pivotal, randomized, double-blind, placebo-controlled study designed to demonstrate the short and long-term efficacy and tolerability of … [Read more…]

Owlet Extends Global Reach with Launch of Medically-Certified Dream Sock™ to South Africa

The wearable baby monitor trusted by millions globally expands reach to three continents, including North America, Europe, and now Africa. JOHANNESBURG–(BUSINESS WIRE)–Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announces the launch of medically-certified Dream Sock™ in South Africa. Distributed as a Class C Medical Device with CE Marking, … [Read more…]

New Data for Genentech’s Vabysmo Reinforce Its Efficacy, Safety and Durability in Wet Age-Related Macular Degeneration (AMD)

– In AVONELLE-X, the largest long-term extension trial in wet AMD, disease control and durability were maintained over 4 years, with nearly 80% of patients on extended dosing by study end – – Over 60% of people with a difficult-to-treat form of wet AMD showed no signs of damaging lesions in the SALWEEN study, and … [Read more…]